Targeting GLP-1 receptor trafficking to improve agonist efficacy (2018)
Attributed to:
Defining the molecular and physiological mechanisms of pancreatic islet dysfunction which lead to type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.60692/w58t2-b9z95
Publication URI: https://gresis.osc.int//doi/10.60692/w58t2-b9z95
Type: Other